Reaction

Blood Follicle Stimulating Hormone Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 389 reports · 9 co-occurring drugs

As of the last recalculation, Blood Follicle Stimulating Hormone Increased appears in 389 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is QUINAPRIL HYDROCHLORIDE (PRR 173.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Quinapril Hydrochloride24173.4173.9
Linagliptin2371.771.7
Busulfan2071.671.7
Glyburide2559.059.0
Octreotide Acetate2648.648.6
Loperamide Hydrochloride And Dimethicone2442.642.7
Bleomycin Sulfate631.531.6
Fludarabine Phosphate2028.628.7
Somatropin2519.419.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.